{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-020410","form_type":"8-K","ticker":"ENVB","cik":"0000890821","company_name":"Enveric Biosciences, Inc.","filed_at":"2026-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.883374+00:00","generated_at":"2026-05-15T01:26:01.725039+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Enveric corrects proxy error: reverse split ratio range is 1-for-5 to 1-for-15, not 1-for-50","bullets":["Corrected reverse split range from erroneously stated 1-for-50 to correct 1-for-15 in proxy statement.","Error appeared on proxy card and notice of internet availability; other proposal text was correct.","Meeting details (May 28, 2026, virtual, all proposals) remain unchanged; supplemental filing made April 30."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-020410","json":"https://secwatch.observer/filing/0001493152-26-020410.json","markdown":"https://secwatch.observer/filing/0001493152-26-020410.md","text":"https://secwatch.observer/filing/0001493152-26-020410.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/890821/000149315226020410/0001493152-26-020410-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/890821/000149315226020410/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T01:26:01.725039+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}